Citation: Chun-Xiong Zheng, Yu Zhao, Yang Liu. Recent Advances in Self-assembled Nano-therapeutics[J]. Chinese Journal of Polymer Science, ;2018, 36(3): 322-346. doi: 10.1007/s10118-018-2078-y shu

Recent Advances in Self-assembled Nano-therapeutics

Chun-Xiong Zheng ^† ,
Yu Zhao ^† ,
Yang Liu ^,

Key Laboratory of Functional Polymer Materials of Ministry of Education, Institute of Polymer Chemistry, College of Chemistry, and State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China

Corresponding author: Yang Liu, yliu@nankai.edu.cn

^†

Received Date: 30 September 2017
Accepted Date: 26 October 2017
Available Online: 26 December 2017

The applications of nanotechnology in biomedicine have gained considerable attentions in recent years owing to the great enhancement of therapeutic efficiency. Integration of self-assembly into nanotechnology has brought tremendous convenience during the formation of nano-carriers. Based on distinctive methods of self-assembly, nano-therapeutics have been developed to an impressive stage with the ability to perform site-specific delivery with temporal and spatial control. This review focuses on the recent advances in the preparing methods for nano-therapeutics, and their applications in the treatments of diseases.
- Self-assembly,
- Nano-therapeutics,
- Hydrophobic effect,
- Electrostatic interaction,
- Supramolecular host-guest interaction
1. [1]
  Salomon J. A., Wang H., Freeman M. K.. Healthy life expectancy for 187 countries, ,1990-2010:a systematic analysis for the global burden of disease study[J]. Lancet, 2013,381(9867):628-628.
2. [2]
  Porter R.. The nature of suffering and the goals of medicine[J]. Hist. Phil. Life Sci., 1997,19(2):297-298.
3. [3]
  Liu Y., Li J., Lu Y.. Enzyme therapeutics for systemic detoxification[J]. Adv. Drug Deliv. Rev., 2015,90(1):24-39.
4. [4]
  Duncan R.. Polymer conjugates as anticancer nanomedicines[J]. Nat. Rev. Cancer, 2006,6(9):688-701. doi: 10.1038/nrc1958
5. [5]
  Farokhzad O. C., Langer R.. Impact of nanotechnology on drug delivery[J]. ACS Nano, 2009,3(1):16-20. doi: 10.1021/nn900002m
6. [6]
  Zhang L., Gu F. X., Chan J. M., Wang A. Z.. Nanoparticles in medicine:Therapeutic applications and developments[J]. Clin. Pharmacol. Ther., 2008,83(5):761-769. doi: 10.1038/sj.clpt.6100400
7. [7]
  Ferrari M.. Cancer nanotechnology:opportunities and challenges[J]. Nat. Rev. Cancer, 2005,5(3):161-171. doi: 10.1038/nrc1566
8. [8]
  Singh K. K.. Nanotechnology in cancer detection and treatment[J]. Technol. Cancer Res. T., 2005,4(6):583-583. doi: 10.1177/153303460500400601
9. [9]
  Couvreur P., Vauthier C.. Nanotechnology:intelligent design to treat complex disease[J]. Pharm. Res., 2006,23(7):1417-1450. doi: 10.1007/s11095-006-0284-8
10. [10]
  Bertrand N., Wu J., Xu X., Kamaly N.. Cancer nanotechnology:the impact of passive and active targeting in the era of modern cancer biology[J]. Adv. Drug Deliv. Rev., 2014,66(1):2-25.
11. [11]
  Ozin G. A., Hou K., Lotsch B. V., Cademartiri L.. Nanofabrication by self-assembly[J]. Mater. Today, 2009,12(5):12-23. doi: 10.1016/S1369-7021(09)70156-7
12. [12]
  Mastrangeli M., Abbasi S., Varel C., Van Hoof C.. Self-assembly from milli-to nanoscales:methods and applications[J]. J. Micromech Microeng., 2009,19(8). doi: 10.1088/0960-1317/19/8/083001
13. [13]
  Bishop K. J., Wilmer C. E., Soh S., Grzybowski B. A.. Nanoscale forces and their uses in self-assembly[J]. Small, 2009,5(14):1600-1630. doi: 10.1002/smll.v5:14
14. [14]
  Peer D., Karp J. M., Hong S., FaroKhzad O. C.. Nanocarriers as an emerging platform for cancer therapy[J]. Nat. Nanotechnol., 2007,2(12):751-760. doi: 10.1038/nnano.2007.387
15. [15]
  Letchford K., Burt H.. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures:micelles, nanospheres, nanocapsules and polymersomes[J]. Eur. J. Pharm. Biopharm., 2007,65(3):259-269. doi: 10.1016/j.ejpb.2006.11.009
16. [16]
  Chandler D.. Interfaces and the driving force of hydrophobic assembly[J]. Nature, 2005,437(7059):640-647. doi: 10.1038/nature04162
17. [17]
  Wang C., Wang Z., Zhang X.. Amphiphilic building blocks for self-assembly:From amphiphiles to supra-amphiphiles[J]. Acc. Chem. Res., 2012,45(4):608-618. doi: 10.1021/ar200226d
18. [18]
  Hill J. P., Shrestha L. K., Ishihara S., Ji Q.. Self-assembly:from amphiphiles to chromophores and beyond[J]. Molecules, 2014,19(6):8589-8609.
19. [19]
  Rösler A., Vandermeulen G. W. M., Klok H. A.. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers[J]. Adv. Drug Deliv. Rev., 2012,64(1):270-279.
20. [20]
  Xiong X. B., Binkhathlan Z., Molavi O., Lavasanifar A.. Amphiphilic block co-polymers:Preparation and application in nanodrug and gene delivery[J]. Acta Biomater., 2012,8(6):2017-2033. doi: 10.1016/j.actbio.2012.03.006
21. [21]
  Aziz Z. A. B. A., Ahmad A., Mohd-Setapar S. H., Hassan H.. Recent advances in drug delivery of polymeric nano-micelles[J]. Curr. Drug Metab., 2017,18(1):16-29. doi: 10.2174/1389200217666160921143616
22. [22]
  Allain V., Bourgaux C., Couvreur P.. Self-assembled nucleolipids:From supramolecular structure to soft nucleic acid and drug delivery devices[J]. Nucleic Acids Res., 2012,40(5):1891-1903. doi: 10.1093/nar/gkr681
23. [23]
  Chen Y., Liang G.. Enzymatic self-assembly of nanostructures for theranostics[J]. Theranostics, 2012,2(2):139-147. doi: 10.7150/thno.3696
24. [24]
  Mai Y., Eisenberg A.. Self-assembly of block copolymers[J]. Chem. Soc. Rev., 2012,41(18):5969-5985. doi: 10.1039/c2cs35115c
25. [25]
  Kim J. K., Yang S. Y., Lee Y., Kim Y.. Functional nanomaterials based on block copolymer self-assembly[J]. Prog. Polym. Sci., 2010,35(11):1325-1349. doi: 10.1016/j.progpolymsci.2010.06.002
26. [26]
  Zhang Z., Ma R., Shi L.. Cooperative macromolecular self-assembly toward polymeric assemblies with multiple and bioactive functions[J]. Acc. Chem. Res., 2014,47(4):1426-1437. doi: 10.1021/ar5000264
27. [27]
  Wu W., Wu D., Li S., Lin Z.. Doxorubicin loaded ph-sensitive micelles for potential tumor therapy[J]. J. Control. Release, 2013,172(1):E72-E73.
28. [28]
  Cheng T., Ma R., Zhang Y., Ding Y.. A surface-adaptive nanocarrier to prolong circulation time and enhance cellular uptake[J]. Chem. Commun., 2015,51(81):14985-14988. doi: 10.1039/C5CC05854F
29. [29]
  Breus V. V., Heyes C. D., Tron K., Nienhaus G. U.. Zwitterionic biocompatible quantum dots for wide ph stability and weak nonspecific binding to cells[J]. ACS Nano, 2009,3(9):2573-2580. doi: 10.1021/nn900600w
30. [30]
  Arvizo R. R., Miranda O. R., Thompson M. A., Pabelick C. M.. Effect of nanoparticle surface charge at the plasma membrane and beyond[J]. Nano Lett., 2010,10(7):2543-2548. doi: 10.1021/nl101140t
31. [31]
  Deshpande M. C., Davies M. C., Garnett M. C., Williams P. M.. The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes[J]. J. Control. Release, 2004,97(1):143-156. doi: 10.1016/j.jconrel.2004.02.019
32. [32]
  Yuan Y. Y., Mao C. Q., Du X. J., Du J. Z.. Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor[J]. Adv. Mater., 2012,24(40):5476-5480. doi: 10.1002/adma.v24.40
33. [33]
  Du J. Z., Sun T. M., Song W. J., Wu J.. A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery[J]. Angew. Chem. Int. Ed., 2010,49(21):3621-3626. doi: 10.1002/anie.200907210
34. [34]
  Xiong M. H., Bao Y., Yang X. Z., Wang Y. C.. Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery[J]. J. Am. Chem. Soc., 2012,134(9):4355-4362. doi: 10.1021/ja211279u
35. [35]
  Du J. Z., Du X. J., Mao C. Q., Wang J.. Tailor-made dual ph-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery[J]. J. Am. Chem. Soc., 2011,133(44):17560-17563. doi: 10.1021/ja207150n
36. [36]
  Pereverzeva E., Treschalin I., Bodyagin D., Maksimenko O.. Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats[J]. Toxicol. Lett., 2008,178(1):9-19. doi: 10.1016/j.toxlet.2008.01.020
37. [37]
  Harker W. G., Sikic B. I.. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line mes-sa[J]. Cancer Res., 1985,45(9):4091-4096.
38. [38]
  Cheng T., Liu J., Ren J., Huang F.. Green tea catechin-based complex micelles combined with doxorubicin to overcome cardiotoxicity and multidrug resistance[J]. Theranostics, 2016,6(9):1277-1292. doi: 10.7150/thno.15133
39. [39]
  Sharma A., Sharma U. S.. Liposomes in drug delivery:Progress and limitations[J]. Int. J. Pharmaceut., 1997,154(2):123-140. doi: 10.1016/S0378-5173(97)00135-X
40. [40]
  Wang Y., Miao L., Satterlee A., Huang L.. Delivery of oligonucleotides with lipid nanoparticles[J]. Adv. Drug Deliv. Rev., 2015,87(1):68-80.
41. [41]
  Goins B., Phillips W. T., Bao A.. Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy[J]. Expert Opin. Drug Deliv., 2016,13(6):873-889.
42. [42]
  Sercombe L., Veerati T., Moheimani F., Wu S. Y.. Advances and challenges of liposome assisted drug delivery[J]. Front Pharmacol., 20156. doi: 10.3389/fphar.2015.00286
43. [43]
  Barenholz Y.. Liposome application:Problems and prospects[J]. Curr. Opin. Colloid Interface Sci., 2001,6(1):66-77. doi: 10.1016/S1359-0294(00)00090-X
44. [44]
  Kraft J. C., Freeling J. P., Wang Z., Ho R. J.. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems[J]. J. Pharm. Sci., 2014,103(1):29-52.
45. [45]
  Chang H. I., Yeh M. K.. Clinical development of liposome-based drugs:Formulation, characterization, and therapeutic efficacy[J]. Int. J. Nanomed., 2012,7(1):49-60.
46. [46]
  Yang F., Jin C., Jiang Y., Li J.. Liposome based delivery systems in pancreatic cancer treatment:From bench to bedside[J]. Cancer Treat Rev., 2011,37(8):633-642. doi: 10.1016/j.ctrv.2011.01.006
47. [47]
  Mo R., Jiang T., Gu Z.. Recent progress in multidrug delivery to cancer cells by liposomes[J]. Nanomedicine, 2014,9(8):1117-1120. doi: 10.2217/nnm.14.62
48. [48]
  Immordino M. L., Dosio F., Cattel L.. Stealth liposomes:Review of the basic science, rationale, and clinical applications, existing and potential[J]. Int. J. Nanomed., 2006,1(3):297-315. doi: 10.2217/17435889.1.3.297
49. [49]
  Wang H., Zhang S., Liao Z., Wang C.. Peglated magnetic polymeric liposome anchored with tat for delivery of drugs across the blood-spinal cord barrier[J]. Biomaterials, 2010,31(25):6589-6596. doi: 10.1016/j.biomaterials.2010.04.057
50. [50]
  Suntres Z. E.. Liposomal antioxidants for protection against oxidant-induced damage[J]. J. Toxicol., 2011. doi: 10.1155/2011/152474
51. [51]
  Zhang X., Guo S., Fan R., Yu M.. Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells[J]. Biomaterials, 2012,33(29):7103-7114. doi: 10.1016/j.biomaterials.2012.06.048
52. [52]
  Wang H., Zhao P., Su W., Wang S.. PLGA/polymeric liposome for targeted drug and gene co-delivery[J]. Biomaterials, 2010,31(33):8741-8748. doi: 10.1016/j.biomaterials.2010.07.082
53. [53]
  Jiang T., Mo R., Bellotti A., Zhou J.. Gel-liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy[J]. Adv. Funct. Mater., 2014,24(16):2295-2304. doi: 10.1002/adfm.v24.16
54. [54]
  Mo R., Jiang T. Y., Gu Z.. Enhanced anticancer efficacy by atp-mediated liposomal drug delivery[J]. Angew. Chem. Int Ed., 2014,53(23):5815-5820. doi: 10.1002/anie.201400268
55. [55]
  Schafer J., Hobel S., Bakowsky U., Aigner A.. Liposome-polyethylenimine complexes for enhanced DNA and sirna delivery[J]. Biomaterials, 2010,31(26):6892-6900. doi: 10.1016/j.biomaterials.2010.05.043
56. [56]
  Rengan A. K., Bukhari A. B., Pradhan A., Malhotra R.. In vivo analysis of biodegradable liposome gold nanoparticles as efficient agents for photothermal therapy of cancer[J]. Nano Lett., 2015,15(2):842-848. doi: 10.1021/nl5045378
57. [57]
  Hubbell J. A., Chilkoti A.. Nanomaterials for drug delivery[J]. Science, 2012,337(6092):303-305. doi: 10.1126/science.1219657
58. [58]
  Park J. H., Lee S., Kim J. H., Park K.. Polymeric nanomedicine for cancer therapy[J]. Prog. Polym. Sci., 2008,33(1):113-137. doi: 10.1016/j.progpolymsci.2007.09.003
59. [59]
  Tong R., Cheng J.. Anticancer polymeric nanomedicines[J]. Polym. Rev., 2007,47(3):345-381. doi: 10.1080/15583720701455079
60. [60]
  Huang P., Wang D., Su Y., Huang W.. Combination of small molecule prodrug and nanodrug delivery:Amphiphilic drug-drug conjugate for cancer therapy[J]. J. Am. Chem. Soc., 2014,136(33):11748-56. doi: 10.1021/ja505212y
61. [61]
  Hu M., Huang P., Wang Y., Su Y.. Synergistic combination chemotherapy of camptothecin and floxuridine through self-assembly of amphiphilic drug-drug conjugate[J]. Bioconjugate. Chem., 2015,26(12):2497-2506. doi: 10.1021/acs.bioconjchem.5b00513
62. [62]
  Zhang T., Huang P., Shi L., Su Y.. Self-assembled nanoparticles of amphiphilic twin drug from floxuridine and bendamustine for cancer therapy[J]. Mol. Pharm., 2015,12(7):2328-2336. doi: 10.1021/acs.molpharmaceut.5b00005
63. [63]
  Ma Y., Mou Q., Sun M., Yu C.. Cancer theranostic nanoparticles self-assembled from amphiphilic small molecules with equilibrium shift-induced renal clearance[J]. Theranostics, 2016,6(10):1703-1716. doi: 10.7150/thno.15647
64. [64]
  Mou Q., Ma Y., Zhu X., Yan D.. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy[J]. J. Control. Release, 2016,230(1):34-44.
65. [65]
  Wang Y., Huang P., Hu M., Huang W.. Self-delivery nanoparticles of amphiphilic methotrexate-gemcitabine prodrug for synergistic combination chemotherapy via effect of deoxyribonucleotide pools[J]. Bioconjugate. Chem., 2016,27(11):2722-2733. doi: 10.1021/acs.bioconjchem.6b00503
66. [66]
  Pack D. W., Hoffman A. S., Pun S., Stayton P. S.. Design and development of polymers for gene delivery[J]. Nat. Rev. Drug Discov., 2005,4(7):581-93. doi: 10.1038/nrd1775
67. [67]
  Xu Z. P., Zeng Q. H., Lu G. Q., Yu A. B.. Inorganic nanoparticles as carriers for efficient cellular delivery[J]. Chem Eng. Sci., 2006,61(3):1027-1040. doi: 10.1016/j.ces.2005.06.019
68. [68]
  Lacerda L., Raffa S., Prato M., Bianco A.. Cell-penetrating cnts for delivery of therapeutics[J]. Nano Today, 2007,2(6):38-43. doi: 10.1016/S1748-0132(07)70172-X
69. [69]
  Mao S., Sun W., Kissel T.. Chitosan-based formulations for delivery of DNA and sirna[J]. Adv. Drug Deliv. Rev., 2010,62(1):12-27. doi: 10.1016/j.addr.2009.08.004
70. [70]
  Chapel J. P., Berret J. F.. Versatile electrostatic assembly of nanoparticles and polyelectrolytes:Coating, clustering and layer-by-layer processes[J]. Curr. Opin. Colloid Interface Sci., 2012,17(2):97-105. doi: 10.1016/j.cocis.2011.08.009
71. [71]
  Shmueli R. B., Anderson D. G., Green J. J.. Electrostatic surface modifications to improve gene delivery[J]. Expert Opin. Drug Deliv., 2010,7(4):535-550. doi: 10.1517/17425241003603653
72. [72]
  Mulligan R. C.. The basic science of gene therapy[J]. Science, 1993,260(5110):926-32. doi: 10.1126/science.8493530
73. [73]
  Liu Y., Du J., Choi J. S., Chen K. J.. A high-throughput platform for formulating and screening multifunctional nanoparticles capable of simultaneous delivery of genes and transcription factors[J]. Angew. Chem. Int. Ed., 2016,55(1):169-173. doi: 10.1002/anie.201507546
74. [74]
  Verma I. M., Somia N.. Gene therapy-promises, problems and prospects[J]. Nature, 1997,389(6648):239-42. doi: 10.1038/38410
75. [75]
  Kircheis R., Wightman L., Wagner E.. Design and gene delivery activity of modified polyethylenimines[J]. Adv. Drug Deliv. Rev., 2001,53(3):341-358. doi: 10.1016/S0169-409X(01)00202-2
76. [76]
  Harris T. J., Green J. J., Fung P. W., Langer R.. Tissue-specific gene delivery via nanoparticle coating[J]. Biomaterials, 2010,31(5):998-1006. doi: 10.1016/j.biomaterials.2009.10.012
77. [77]
  Liu Y., Wang H., Kamei K. I., Yan M.. Delivery of intact transcription factor by using self-assembled supramolecular nanoparticles[J]. Angew. Chem. Int. Ed., 2011,50(13):3058-3062. doi: 10.1002/anie.201005740
78. [78]
  Won Y. W., Adhikary P. P., Lim K. S., Kim H. J.. Oligopeptide complex for targeted non-viral gene delivery to adipocytes[J]. Nat. Mater., 2014,13(12):1157-1164. doi: 10.1038/nmat4092
79. [79]
  Ariga K., Lvov Y. M., Kawakami K., Ji Q.. Layer-by-layer self-assembled shells for drug delivery[J]. Adv. Drug Deliv. Rev., 2011,63(9):762-771. doi: 10.1016/j.addr.2011.03.016
80. [80]
  Ariga K., Yamauchi Y., Rydzek G., Ji Q.. Layer-by-layer nanoarchitectonics:Invention, innovation, and evolution[J]. Chem Lett., 2014,43(1):36-68. doi: 10.1246/cl.130987
81. [81]
  Fujii N., Fujimoto K., Michinobu T., Akada M.. The simplest layer-by-layer assembly structure:Best paired polymer electrolytes with one charge per main chain carbon atom for multi layered thin films[J]. Macromolecules, 2010,43(8):3947-3955. doi: 10.1021/ma100473j
82. [82]
  Lvov Y., Onda M., Ariga K., Kunitake T.. Ultrathin films of charged polysaccharides assembled alternately with linear polyions[J]. J. Biomat. Sci. Polym. E, 1998,9(4):345-355. doi: 10.1080/09205063.1998.9753060
83. [83]
  Katagiri K., Hamasaki R., Ariga K., Kikuchi J.. Layered paving of vesicular nanoparticles formed with cerasome as a bioinspired organic-inorganic hybrid[J]. J. Am. Chem. Soc., 2002,124(27):7892-7893. doi: 10.1021/ja0259281
84. [84]
  Elbakry A., Zaky A., Liebkl R., Rachel R.. Layer-by-layer assembled gold nanoparticles for sirna delivery[J]. Nano Lett., 2009,9(5):2059-2064. doi: 10.1021/nl9003865
85. [85]
  Saurer E. M., Flessner R. M., Sullivan S. P., Prausnitz M. R.. Layer-by-layer assembly of DNA-and protein-containing films on microneedles for drug delivery to the skin[J]. Biomacromolecules, 2010,11(11):3136-3143. doi: 10.1021/bm1009443
86. [86]
  Morton S. W., Shah N. J., Quadir M. A., Deng Z. J.. Osteotropic therapy via targeted layer-by-layer nanoparticles[J]. Adv. Healthc. Mater., 2014,3(6):867-75. doi: 10.1002/adhm.201300465
87. [87]
  Shutava T. G., Balkundi S. S., Vangala P., Steffan J. J.. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols[J]. ACS Nano, 2009,3(7):1877-1885. doi: 10.1021/nn900451a
88. [88]
  Agarwal A., Lvov Y., Sawant R., Torchilin V.. Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology[J]. J. Control. Release, 2008,128(3):255-260. doi: 10.1016/j.jconrel.2008.03.017
89. [89]
  Pargaonkar N., Lvov Y. M., Li N., Steenekamp J. H.. Controlled release of dexamethasone from microcapsules produced by polyelectrolyte layer-by-layer nanoassembly[J]. Pharm. Res., 2005,22(5):826-835. doi: 10.1007/s11095-005-2600-0
90. [90]
  Deng Z. J., Morton S. W., Ben-Akiva E., Dreaden E. C.. Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and sirna for potential triple-negative breast cancer treatment[J]. ACS Nano, 2013,7(11):9571-9584. doi: 10.1021/nn4047925
91. [91]
  Poon Z., Chang D., Zhao X., Hammond P. T.. Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia[J]. ACS Nano, 2011,5(6):4284-4292. doi: 10.1021/nn200876f
92. [92]
  Kim B. S., Park S. W., Hammond P. T.. Hydrogen-bonding layer-by-layer assembled biodegradable polymeric micelles as drug delivery vehicles from surfaces[J]. ACS Nano, 2008,2(2):386-392. doi: 10.1021/nn700408z
93. [93]
  Ma X., Zhao Y.. Biomedical applications of supramolecular systems based on host-guest interactions[J]. Chem. Rev., 2015,115(15):7794-7839. doi: 10.1021/cr500392w
94. [94]
  Karim A. A., Dou Q., Li Z., Loh X. J.. Emerging supramolecular therapeutic carriers based on host-guest interactions[J]. Chem. Asian J., 2016,11(9):1300-1321. doi: 10.1002/asia.v11.9
95. [95]
  Hu J., Liu S.. Engineering responsive polymer building blocks with host-guest molecular recognition for functional applications[J]. Acc. Chem. Res., 2014,47(7):2084-2095. doi: 10.1021/ar5001007
96. [96]
  Zhang J., Ma P. X.. Cyclodextrin-based supramolecular systems for drug delivery:Recent progress and future perspective[J]. Adv. Drug Deliv. Rev., 2013,65(9):1215-1233. doi: 10.1016/j.addr.2013.05.001
97. [97]
  Wang L., Li L. L., Fan Y. S., Wang H.. Host-guest supramolecular nanosystems for cancer diagnostics and therapeutics[J]. Adv. Mater., 2013,25(28):3888-3898. doi: 10.1002/adma.v25.28
98. [98]
  Challa R., Ahuja A., Ali J., Khar R. K.. Cyclodextrins in drug delivery:An updated review[J]. AAPS PharmSciTech., 2005,6(2):E329-E357. doi: 10.1208/pt060243
99. [99]
  Stella V. J., Rajewski R. A.. Cyclodextrins:Their future in drug formulation and delivery[J]. Pharm. Res-Dordr., 1997,14(5):556-567. doi: 10.1023/A:1012136608249
100. [100]
  Gref R., Amiel C., Molinard K., Daoud-Mahammed S.. New self-assembled nanogels based on host-guest interactions:Characterization and drug loading[J]. J. Control. Release, 2006,111(3):316-324. doi: 10.1016/j.jconrel.2005.12.025
101. [101]
  Zhang J., Ma P. X.. Polymeric core-shell assemblies mediated by host-guest interactions:versatile nanocarriers for drug delivery[J]. Angew. Chem. Int. Ed., 2009,48(5):964-968. doi: 10.1002/anie.v48:5
102. [102]
  Hu Q. D., Tang G. P., Chu P. K.. Cyclodextrin-based host-guest supramolecular nanoparticles for delivery:from design to applications[J]. Acc. Chem. Res., 2014,47(7):2017-2025. doi: 10.1021/ar500055s
103. [103]
  Wang H., Wang S., Su H., Chen K. J.. A supramolecular approach for preparation of size-controlled nanoparticles[J]. Angew. Chem. Int. Ed., 2009,48(24):4344-4318. doi: 10.1002/anie.v48:24
104. [104]
  Ang C.Y., Tan S. Y., Wang X., Zhang Q.. Supramolecular nanoparticle carriers self-assembled from cyclodextrin-and adamantane-functionalized polyacrylates for tumor-targeted drug delivery[J]. J. Mater. Chem. B, 2014,2(13):1879-1890. doi: 10.1039/c3tb21325k
105. [105]
  Qu D. H., Wang Q. C., Zhang Q. W., Ma X.. Photoresponsive host-guest functional systems[J]. Chem. Rev., 2015,115(15):7543-7588. doi: 10.1021/cr5006342
106. [106]
  Dan Z., Cao H., He X., Zeng L.. Biological stimuli-responsive cyclodextrin-based host-guest nanosystems for cancer therapy[J]. Int. J. Pharm., 2015,483(1-2):63-68. doi: 10.1016/j.ijpharm.2015.01.035
107. [107]
  Zhang W., Li Y., Sun J. H., Tan C. P.. Supramolecular self-assembled nanoparticles for chemo-photodynamic dual therapy against cisplatin resistant cancer cells[J]. Chem. Commun., 2015,51(10):1807-1810. doi: 10.1039/C4CC08583C
108. [108]
  Wang Y., Li D., Jin Q., Ji J.. pH-responsive supramolecular prodrug micelles based on cucurbit 8 uril for intracellular drug delivery[J]. J Control. Release, 2015,213(1):E134-E135.
109. [109]
  Yu G., Jie K., Huang F.. Supramolecular amphiphiles based on host-guest molecular recognition motifs[J]. Chem. Rev., 2015,115(15):7240-7303. doi: 10.1021/cr5005315
110. [110]
  Yang B., Dong X., Lei Q., Zhuo R.. Host-guest interaction-based self-engineering of nano-sized vesicles for co-delivery of genes and anticancer drugs[J]. ACS Appl. Mater. Interfaces, 2015,7(39):22084-22094. doi: 10.1021/acsami.5b07549
111. [111]
  Liu Y., Yu C., Jin H., Jiang B.. A supramolecular janus hyperbranched polymer and its photoresponsive self-assembly of vesicles with narrow size distribution[J]. J. Am. Chem. Soc., 2013,135(12):4765-4770. doi: 10.1021/ja3122608
112. [112]
  Li Y., Liu Y., Ma R., Xu Y.. A g-quadruplex hydrogel via multicomponent self-assembly:Formation and zero-order controlled release[J]. ACS Appl. Mater. Interfaces, 2017,9(15):13056-13067. doi: 10.1021/acsami.7b00957
113. [113]
  Zhao L., Qu R., Li A., Ma R.. Cooperative self-assembly of porphyrins with polymers possessing bioactive functions[J]. Chem. Commun., 2016,52(93):13543-13555. doi: 10.1039/C6CC05449H
114. [114]
  Gu Z., Biswas A., Zhao M., Tang Y.. Tailoring nanocarriers for intracellular protein delivery[J]. Chem. Soc. Rev., 2011,40(7):3638-3655. doi: 10.1039/c0cs00227e
115. [115]
  Yan M., Ge J., Liu Z., Ouyang P.. Encapsulation of single enzyme in nanogel with enhanced biocatalytic activity and stability[J]. J. Am. Chem. Soc., 2006,128(34):11008-11009. doi: 10.1021/ja064126t
116. [116]
  Yan M., Du J., Gu Z., Liang M.. A novel intracellular protein delivery platform based on single-protein nanocapsules[J]. Nat. Nanotechnol., 2010,5(1):48-53. doi: 10.1038/nnano.2009.341
117. [117]
  Gu Z., Yan M., Hu B., Joo K. I.. Protein nanocapsule weaved with enzymatically degradable polymeric network[J]. Nano Lett., 2009,9(12):4533-4538. doi: 10.1021/nl902935b
118. [118]
  Wen J., Anderson S. M., Du J., Yan M.. Controlled protein delivery based on enzyme-responsive nanocapsules[J]. Adv. Mater., 2011,23(39):4549-53. doi: 10.1002/adma.201101771
119. [119]
  Liang S., Liu Y., Jin X., Liu G.. Phosphorylcholine polymer nanocapsules prolong the circulation time and reduce the immunogenicity of therapeutic proteins[J]. Nano Res., 2016,9(4):1022-1031. doi: 10.1007/s12274-016-0991-3
120. [120]
  Zhao M., Hu B., Gu Z., Joo K. I.. Degradable polymeric nanocapsule for efficient intracellular delivery of a high molecular weight tumor-selective protein complex[J]. Nano Today, 2013,8(1):11-20. doi: 10.1016/j.nantod.2012.12.003
121. [121]
  Tian H., Du J., Wen J., Liu Y.. Growth-factor nanocapsules that enable tunable controlled release for bone regeneration[J]. ACS Nano, 2016,10(8):7362-7369. doi: 10.1021/acsnano.5b07950
122. [122]
  Liu C., Wen J., Meng Y., Zhang K.. Efficient delivery of therapeutic mirna nanocapsules for tumor suppression[J]. Adv. Mater., 2015,27(2):292-297. doi: 10.1002/adma.v27.2
123. [123]
  Peer D., Karp J. M., Hong S., FaroKHzad O. C.. Nanocarriers as an emerging platform for cancer therapy[J]. Nat. Nanotechnol., 2007,2(12):751-760. doi: 10.1038/nnano.2007.387
124. [124]
  Wang M., Thanou M.. Targeting nanoparticles to cancer[J]. Pharmacol. Res., 2010,62(2):90-99. doi: 10.1016/j.phrs.2010.03.005
125. [125]
  DeSantis C. E., Lin C. C., Mariotto A. B., Siegel R. L.. Cancer treatment and survivorship statistics, ,2014[J]. CA:A Cancer Journal for Clinicians, 2014,64(4):252-271. doi: 10.3322/caac.v64.4
126. [126]
  Sun T. M., Zhang Y. S., Pang B., Hyun D. C.. Engineered nanoparticles for drug delivery in cancer therapy[J]. Angew. Chem. Int. Ed., 2014,53(46):12320-12364.
127. [127]
  Liu Y., Li J., Lu Y. F.. Enzyme therapeutics for systemic detoxification[J]. Adv. Drug Deliv. Rev., 2015,90:24-39. doi: 10.1016/j.addr.2015.05.005
128. [128]
  Bae Y. H., Park K.. Targeted drug delivery to tumors:myths, reality and possibility[J]. J. Control. Release, 2011,153(3):198-205. doi: 10.1016/j.jconrel.2011.06.001
129. [129]
  LaVan D. A., McGuire T., Langer R.. Small-scale systems for in vivo drug delivery[J]. Nat. Biotechnol., 2003,21(10):1184-1191. doi: 10.1038/nbt876
130. [130]
  Ganta S., Devalapally H., Shahiwala A., Amiji M.. A review of stimuli-responsive nanocarriers for drug and gene delivery[J]. J. Control. Release, 2008,126(3):187-204. doi: 10.1016/j.jconrel.2007.12.017
131. [131]
  Wang G., Uludag H.. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles[J]. Expert Opin. Drug Deliv., 2008,5(5):499-515. doi: 10.1517/17425247.5.5.499
132. [132]
  Gao H., Cheng T., Liu J., Liu J.. Self-regulated multifunctional collaboration of targeted nanocarriers for enhanced tumor therapy[J]. Biomacromolecules, 2014,15(10):3634-3642. doi: 10.1021/bm5009348
133. [133]
  Shuhendler A. J., Prasad P., Leung M., Rauth A. M.. A novel solid lipid nanoparticle formulation for active targeting to tumor alpha(v)beta(3) integrin receptors reveals cyclic rgd as a double-edged sword[J]. Adv. Healthc. Mater., 2012,1(5):600-608. doi: 10.1002/adhm.201200006
134. [134]
  Cheng T. J., Ma R. J., Zhang Y. M., Ding Y. X.. A surface-adaptive nanocarrier to prolong circulation time and enhance cellular uptake[J]. Chem. Commun., 2015,51(81):14985-14988. doi: 10.1039/C5CC05854F
135. [135]
  Falamarzian A., Lavasanifar A.. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(epsilon-caprolactone) based nano-carriers for the solubilization and delivery of amphotericin b[J]. Colloids and Surfaces B-Biointerfaces, 2010,81(1):313-320. doi: 10.1016/j.colsurfb.2010.07.025
136. [136]
  Gao H. J., Xiong J., Cheng T. J., Liu J. J.. In vivo biodistribution of mixed shell micelles with tunable hydrophilic/hydrophobic surface[J]. Biomacromolecules, 2013,14(2):460-467. doi: 10.1021/bm301694t
137. [137]
  Wang H. X., Yang X. Z., Sun C. Y., Mao C. Q.. Matrix metalloproteinase 2-responsive micelle for sirna delivery[J]. Biomaterials, 2014,35(26):7622-7634. doi: 10.1016/j.biomaterials.2014.05.050
138. [138]
  Sun C. Y., Shen S., Xu C. F., Li H. J.. Tumor acidity-sensitive polymeric vector for active targeted sirna delivery[J]. J. Am. Chem. Soc., 2015,137(48):15217-15224. doi: 10.1021/jacs.5b09602
139. [139]
  Guan X., Guo Z., Lin L., Chen J.. Ultrasensitive pH triggered charge/size dual-rebound gene delivery system[J]. Nano Lett., 2016,16(11):6823-6831. doi: 10.1021/acs.nanolett.6b02536
140. [140]
  Wakebayashi D., Nishiyama N., Yamasaki Y., Itaka K.. Lactose-conjugated polyion complex micelles incorporating plasmid DNA as a targetable gene vector system:Their preparation and gene transfecting efficiency against cultured HEPG2 cells[J]. J. Control. Release, 2004,95(3):653-664. doi: 10.1016/j.jconrel.2004.01.003
141. [141]
  Harada A., Kataoka K.. Pronounced activity of enzymes through the incorporation into the core of polyion complex micelles made from charged block copolymers[J]. J. Control. Release, 2001,72(1-3):85-91. doi: 10.1016/S0168-3659(01)00264-4
142. [142]
  Dufresne M. H., Leroux J. C.. Study of the micellization behavior of different order amino block copolymers with heparin[J]. Pharm. Res., 2004,21(1):160-169. doi: 10.1023/B:PHAM.0000012164.60867.c6
143. [143]
  Biswas A., Joo K. I., Liu J., Zhao M. X.. Endoprotease-mediated intracellular protein delivery using nanocapsules[J]. ACS Nano, 2011,5(2):1385-1394. doi: 10.1021/nn1031005
144. [144]
  Liu Y., Wang H., Kamei K., Yan M.. Delivery of intact transcription factor by using self-assembled supramolecular nanoparticles[J]. Angew. Chem. Int. Ed., 2011,50(13):3058-3062. doi: 10.1002/anie.201005740
145. [145]
  Govender T., Stolnik S., Xiong C., Zhang S.. Drug-polyionic block copolymer interactions for micelle formation:Physicochemical characterisation[J]. J. Control. Release, 2001,75(3):249-258. doi: 10.1016/S0168-3659(01)00353-4
146. [146]
  Safra T., Muggia F., Jeffers S., Tsao-Wei D. D.. Pegylated liposomal doxorubicin (doxil):Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m(2)[J]. Ann Oncol., 2000,11(8):1029-1033. doi: 10.1023/A:1008365716693
147. [147]
  Cho K. J., Wang X., Nie S. M., Chen Z.. Therapeutic nanoparticles for drug delivery in cancer[J]. Clin. Cancer Res., 2008,14(5):1310-1316. doi: 10.1158/1078-0432.CCR-07-1441
148. [148]
  Koudelka S., Turanek J.. Liposomal paclitaxel formulations[J]. J. Control. Release, 2012,163(3):322-334. doi: 10.1016/j.jconrel.2012.09.006
149. [149]
  Lim W. T., Leong S. S., Toh C. K., Ang C. S.. A phase i pharmacokinetic study of a liposomal formulation of paclitaxel administered weekly to Asian patients with solid malignancies[J]. J. Clin. Oncol., 2009,27(15)2581.
150. [150]
  Markman M.. Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary[J]. Expert Opin. Pharmaco., 2006,7(11):1469-1474. doi: 10.1517/14656566.7.11.1469
151. [151]
  Gaspar M. M., Perez-Soler R., Cruz M. E.. Biological characterization of l-asparaginase liposomal formulations[J]. Cancer Chemother. Pharmacol., 1996,38(4):373-377. doi: 10.1007/s002800050497
152. [152]
  Felgner P. L., Holm M., Chan H.. Cationic liposome mediated transfection[J]. Proc. West Pharmacol. Soc., 1989,32:115-121.
153. [153]
  Felgner P. L., Ringold G. M.. Cationic liposome-mediated transfection[J]. Nature, 1989,337(6205):387-388. doi: 10.1038/337387a0
154. [154]
  Murray K. D., McQuillin A., Stewart L., Etheridge C. J.. Cationic liposome-mediated DNA transfection in organotypic explant cultures of the ventral mesencephalon[J]. Gene Ther., 1999,6(2):190-197. doi: 10.1038/sj.gt.3300743
155. [155]
  Kim J. K., Choi S. H., Kim C. O., Park J. S.. Enhancement of polyethylene glycol (PEG)-modified cationic liposomemediated gene deliveries:effects on serum stability and transfection efficiency[J]. J. Pharm. Pharmacol., 2003,55(4):453-460. doi: 10.1211/002235702928
156. [156]
  Zhu L., Kate P., Torchilin V. P.. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting[J]. ACS Nano, 2012,6(4):3491-3498. doi: 10.1021/nn300524f
157. [157]
  Anonymous. Classification and diagnosis of diabetes. Diabetes Care 2015, 38(Suppl. 1), S8-S16.
158. [158]
  Craft S.. The role of metabolic disorders in alzheimer disease and vascular dementia:Two roads converged[J]. Arch. Neurol., 2009,66(3):300-305.
159. [159]
  Canivell S., Gomis R.. Diagnosis and classification of autoimmune diabetes mellitus[J]. Autoimmun. Rev., 2014,13(4-5):403-407. doi: 10.1016/j.autrev.2014.01.020
160. [160]
  Abdi H., Hosseinpanah F., Azizi F., Hadaegh F.. Screening for dysglycemia:a comment on classification and diagnosis of diabetes in american diabetes association standards of medical care in diabetes-, 2016[J]. Arch. Iran. Med., 2017,20(6):389-389.
161. [161]
  Yang H., Zhang C., Li C., Liu Y.. Glucose-responsive polymer vesicles templated by alpha-CD/PEG inclusion complex[J]. Biomacromolecules, 2015,16(4):1372-1381. doi: 10.1021/acs.biomac.5b00155
162. [162]
  Yang H., Ma R., Yue J., Li C.. A facile strategy to fabricate glucose-responsive vesicles via a template of thermo-sensitive micelles[J]. Polym. Chem., 2015,6(20):3837-3846. doi: 10.1039/C5PY00170F
163. [163]
  Zhao L., Xiao C. S., Wang L. Y., Gai G. Q.. Glucose-sensitive polymer nanoparticles for self-regulated drug delivery[J]. Chem. Commun., 2016,52(49):7633-7652. doi: 10.1039/C6CC02202B
164. [164]
  Wang B. L., Ma R. J., Liu G., Li Y.. Glucose-responsive micelles from self-assembly of poly(ethylene glycol)-b-poly(acrylic acid-co-acrylamidophenylboronic acid) and the controlled release of insulin[J]. Langmuir, 2009,25(21):12522-12528. doi: 10.1021/la901776a
165. [165]
  Cambre J. N., Sumerlin B. S.. Biomedical applications of boronic acid polymers[J]. Polymer, 2011,52(21):4631-4643. doi: 10.1016/j.polymer.2011.07.057
166. [166]
  Liu G., Ma R. J., Ren J., Li Z.. A glucose-responsive complex polymeric micelle enabling repeated on-off release and insulin protection[J]. Soft Matter, 2013,9(5):1636-1644. doi: 10.1039/C2SM26690C
167. [167]
  Selkoe D. J., Schenk D.. Alzheimer's disease:Molecular understanding predicts amyloid-based therapeutics[J]. Annu. Rev. Pharmacol. Toxicol, 2003,43:545-84. doi: 10.1146/annurev.pharmtox.43.100901.140248
168. [168]
  Small D. H., Losic D., Martin L. L., Turner B. J.. Alzheimer's disease therapeutics:new approaches to an ageing problem[J]. IUBMB Life., 2004,56(4):203-208. doi: 10.1080/15216540410001709211
169. [169]
  Anand R., Gill K. D., Mahdi A. A.. Therapeutics of alzheimer's disease:Past, present and future[J]. Neuropharmacology, 2014,76:27-50. doi: 10.1016/j.neuropharm.2013.07.004
170. [170]
  Rafii M. S.. Preclinical alzheimer's disease therapeutics[J]. J. Alzheimers Dis., 2014,42(Suppl. 4):S545-S549.
171. [171]
  Kelleher-Andersson J.. Discovery of neurogenic, alzheimer's disease therapeutics[J]. Curr. Alzheimer Res., 2006,3(1):55-62. doi: 10.2174/156720506775697179
172. [172]
  Boada M., Ortiz P., Anaya F., Hernandez I.. Amyloid-targeted therapeutics in alzheimer's disease:Use of human albumin in plasma exchange as a novel approach for a beta mobilization[J]. Drug News Perspect., 2009,22(6):325-339. doi: 10.1358/dnp.2009.22.6.1395256
173. [173]
  Shvaloff A., Neuman E., Guez D.. Lines of therapeutics research in alzheimer's disease[J]. Psychopharmacol. Bull., 1996,32(3):343-352.
174. [174]
  Hardy J., Selkoe D. J.. Medicine-he amyloid hypothesis of alzheimer's disease:Progress and problems on the road to therapeutics[J]. Science, 2002,297(5580):353-356. doi: 10.1126/science.1072994
175. [175]
  Dennis J., Selkoe M. D.. The therapeutics of Alzheimer's disease:Where we stand and where we are heading[J]. Ann. Neurol., 2013,74(3):328-336. doi: 10.1002/ana.v74.3
176. [176]
  Horwich A. L.. Molecular chaperones in cellular protein folding:The birth of a field[J]. Cell, 2014,157(2):285-288. doi: 10.1016/j.cell.2014.03.029
177. [177]
  Baneyx F., Thomas J. G.. Collaboration of major and minor molecular chaperones in cellular protein folding[J]. Abstracts of Papers of the American Chemical Society., 2000,219:U179-U180.
178. [178]
  Huang F., Wang J. Z., Qu A. T., Shen L. L.. Maintenance of amyloid beta peptide homeostasis by artificial chaperones based on mixed-shell polymeric micelles[J]. Angew. Chem. Int. Ed., 2014,53(34):8985-8990. doi: 10.1002/anie.201400735
179. [179]
  Wang J., Song Y., Sun P., An Y.. Reversible interactions of proteins with mixed shell polymeric micelles:Tuning the surface hydrophobic/hydrophilic balance toward efficient artificial chaperones[J]. Langmuir, 2016,32(11):2737-2749. doi: 10.1021/acs.langmuir.6b00356
180. [180]
  Huang F., Shen L., Wang J., Qu A.. Effect of the surface charge of artificial chaperones on the refolding of thermally denatured lysozymes[J]. ACS Appl. Mater. Interfaces, 2016,8(6):3669-3678. doi: 10.1021/acsami.5b08843
181. [181]
  Wang J., Yin T., Huang F., Song Y.. Artificial chaperones based on mixed shell polymeric micelles:Insight into the mechanism of the interaction of the chaperone with substrate proteins using forster resonance energy transfer[J]. ACS Appl. Mater. Interfaces, 2015,7(19):10238-10249. doi: 10.1021/acsami.5b00684
182. [182]
  Watanabe K., Nakamura K., Akikusa S., Okada T.. Inhibitors of fibril formation and cytotoxicity of beta-amyloid peptide composed of KLVFF recognition element and flexible hydrophilic disrupting element[J]. Biochem. Biophys. Res. Commun., 2002,290(1):121-124. doi: 10.1006/bbrc.2001.6191
183. [183]
  Tjernberg L. O., Naslund J., Lindqvist F., Johansson J.. Arrest of beta-amyloid fibril formation by a pentapeptide ligand[J]. J. Biol. Chem., 1996,271(15):8545-8. doi: 10.1074/jbc.271.15.8545
184. [184]
  Liu F. F., Du W. J., Sun Y., Zheng J.. Atomistic characterization of binding modes and affinity of peptide inhibitors to amyloid-beta protein[J]. Front. Chem. Sci. Eng., 2014,8(4):433-444. doi: 10.1007/s11705-014-1454-6
185. [185]
  Qu A. T., Huang F., Li A., Yang H. R.. The synergistic effect between KLVFF and self-assembly chaperones on both disaggregation of beta-amyloid fibrils and reducing consequent toxicity[J]. Chem. Commun., 2017,53(7):1289-1292. doi: 10.1039/C6CC07803F
186. [186]
  Vonghia L., Leggio L., Ferrulli A., Bertini M.. Acute alcohol intoxication[J]. Eur. J. Intern. Med., 2008,19(8):561-567. doi: 10.1016/j.ejim.2007.06.033
187. [187]
  Kantrow S. P., Shen Z., Zhang P., Ramsey J.. Acute alcohol intoxication, lung permeability and host defense[J]. Alcohol. Clin. Exp. Res., 2008,32(6):172a-172a.
188. [188]
  Gerstman M. D., Merry A. F., McIlroy D. R., Hannam J. A.. Acute alcohol intoxication and bispectral index monitoring[J]. Acta Anaesth. Scand., 2015,59(8):1015-1021. doi: 10.1111/aas.2015.59.issue-8
189. [189]
  Sellers E. M., Kalant H.. Drug-therapy-alcohol intoxication and withdrawal[J]. New Eng. J. of Med., 1976,294(14):757-762. doi: 10.1056/NEJM197604012941405
190. [190]
  Robertson C. C., Sellers E. M.. Alcohol intoxication and alcohol withdrawal syndrome[J]. Postgrad. Med., 1978,64(6):133-138. doi: 10.1080/00325481.1978.11715005
191. [191]
  Sellers E. M., Kalant H.. Alcohol intoxication and withdrawal[J]. New. Engl. J. Med., 1976,294(14):757-762. doi: 10.1056/NEJM197604012941405
192. [192]
  Shpilenya L. S., Muzychenko A. P., Gasbarrini G., Addolorato G.. Metadoxine in acute alcohol intoxication:A double-blind, randomized, placebo-controlled study[J]. Alcohol. Clin. Exp. Res., 2002,26(3):340-346. doi: 10.1111/acer.2002.26.issue-3
193. [193]
  Liu Y., Du J. J., Yan M., Lau M. Y.. Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication[J]. Nat. Nanotechnol., 2013,8(3):187-192. doi: 10.1038/nnano.2012.264
194. [194]
  Munoz-Bonilla A., Fernandez-Garcia M.. Polymeric materials with antimicrobial activity[J]. Prog. Polym. Sci., 2012,37(2):281-339. doi: 10.1016/j.progpolymsci.2011.08.005
195. [195]
  Pelgrift R. Y., Friedman A. J.. Nanotechnology as a therapeutic tool to combat microbial resistance[J]. Adv. Drug Deliv. Rev., 2013,65(13-14):1803-1815. doi: 10.1016/j.addr.2013.07.011
196. [196]
  Zhang L., Pornpattananangkul D., Hu C. M. J., Huang C. M.. Development of nanoparticles for antimicrobial drug delivery[J]. Currt. Med. Chem., 2010,17(6):585-594. doi: 10.2174/092986710790416290
197. [197]
  Zhang Y., Chan H. F., Leong K. W.. Advanced materials and processing for drug delivery:the past and the future[J]. Adv. Drug Deliv. Rev., 2013,65(1):104-120. doi: 10.1016/j.addr.2012.10.003
198. [198]
  Peltonen L. I., Kinnari T. J., Aarnisalo A. A., Kuusela P.. Comparison of bacterial adherence to polylactides, silicone, and titanium[J]. Acta Oto-Laryngologica, 2007,127(6):587-593. doi: 10.1080/00016480600987792
199. [199]
  Kornman K. S.. Controlled-release local delivery antimicrobials in periodontics:prospects for the future[J]. J Periodontol., 1993,64(8 Suppl):782-791.
200. [200]
  Smith A. W.. Biofilms and antibiotic therapy:Is there a role for combating bacterial resistance by the use of novel drug delivery systems?[J]. Adv. Drug Deliv. Rev., 2005,57(10):1539-1550. doi: 10.1016/j.addr.2005.04.007
201. [201]
  Hittinger M., Juntke J., Kletting S., Schneider-Daum N.. Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models[J]. Adv. Drug Deliv. Rev., 2015,85:44-56. doi: 10.1016/j.addr.2014.10.011
202. [202]
  Arthur T. D., Cavera V. L., Chikindas M. L.. On bacteriocin delivery systems and potential applications[J]. Future Microbiol., 2014,9(2):235-248. doi: 10.2217/fmb.13.148
203. [203]
  Herbrecht R., Denning D. W., Patterson T. F., Bennett J. E.. Voriconazole versus amphotericin b for primary therapy of invasive aspergillosis[J]. New Engl. J. Med., 2002,347(6):408-415. doi: 10.1056/NEJMoa020191
204. [204]
  Walsh T. J., Teppler H., Donowitz G. R., Maertens J. A.. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia[J]. New Engl. J. Med., 2004,351(14):1391-1402. doi: 10.1056/NEJMoa040446
205. [205]
  Kim H. J., Jones M. N.. The delivery of benzyl penicillin to staphylococcus aureus biofilms by use of liposomes[J]. J. Liposome Res., 2004,14(3-4):123-139. doi: 10.1081/LPR-200029887
206. [206]
  Pinto-Alphandary H., Andremont A., Couvreur P.. Targeted delivery of antibiotics using liposomes and nanoparticles:Research and applications[J]. Int. J. Antimicrob. Agents, 2000,13(3):155-168. doi: 10.1016/S0924-8579(99)00121-1
207. [207]
  Onyeji C. O., Nightingale C. H., Marangos M. N.. Enhanced killing of methicillin-resistant staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin[J]. Infection, 1994,22(5):338-342. doi: 10.1007/BF01715542
208. [208]
  Schumacher I., Margalit R.. Liposome-encapsulated ampicillin:Physicochemical and antibacterial properties[J]. J. Pharm. Sci., 1997,86(5):635-641. doi: 10.1021/js9503690
209. [209]
  Huang F., Gao Y., Zhang Y., Cheng T.. Silver-decorated polymeric micelles combined with curcumin for enhanced antibacterial activity[J]. ACS Appl. Mater. Interfaces, 2017,9(20):16881-16890.
210. [210]
  Chu L., Gao H., Cheng T., Zhang Y.. A charge-adaptive nanosystem for prolonged enhanced in vivo antibiotic delivery[J]. Chem. Commun., 2016,52(37):6265-6268. doi: 10.1039/C6CC01269H
211. [211]
  Shah L. K., Amiji M. M.. Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS[J]. Pharm. Res., 2006,23(11):2638-2645. doi: 10.1007/s11095-006-9101-7
212. [212]
  Mosqueira V. C. F., Loiseau P. M., Bories C., Legrand P.. Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in plasmodium berghei-infected mice[J]. Antimicrob. Agents Ch., 2004,48(4):1222-1228. doi: 10.1128/AAC.48.4.1222-1228.2004
213. [213]
  Liu Y., Busscher H. J., Zhao B. R., Li Y.. F[J]. Surface-adaptive, antimicrobially loaded, micellar nanocarriers with enhanced penetration and killing efficiency in staphylococcal biofilms. ACS Nano, 2016,10(4):4779-4789.
214. [214]
  Li Y. M., Liu G. H., Wang X. R., Hu J. M.. Enzyme-responsive polymeric vesicles for bacterial-strainselective delivery of antimicrobial agents[J]. Angew. Chem. Int. Ed., 2016,55(5):1760-1764. doi: 10.1002/anie.201509401
215. [215]
  Hasan J., Crawford R. J., Lvanova E. P.. Antibacterial surfaces:the quest for a new generation of biomaterials[J]. Trends Biotechnol., 2013,31(5):31-40.
216. [216]
  Insua I., Liamas E., Zhang Z. Y., Peacock A. F. A.. Enzyme-responsive polyion complex (PIC) nanoparticles for the targeted delivery of antimicrobial polymers[J]. Polym. Chem., 2016,7(15):2684-2690. doi: 10.1039/C6PY00146G
1. [1]
  Zhibin Ren , Shan Li , Xiaoying Liu , Guanghao Lv , Lei Chen , Jingli Wang , Xingyi Li , Jiaqing Wang . Penetrating efficiency of supramolecular hydrogel eye drops: Electrostatic interaction surpasses ligand-receptor interaction. Chinese Chemical Letters, 2024, 35(11): 109629-. doi: 10.1016/j.cclet.2024.109629
2. [2]
  Xuanyu Wang , Zhao Gao , Wei Tian . Supramolecular confinement effect enabling light-harvesting system for photocatalytic α-oxyamination reaction. Chinese Chemical Letters, 2024, 35(11): 109757-. doi: 10.1016/j.cclet.2024.109757
3. [3]
  Yuanpeng Ye , Longfei Yao , Guofeng Liu . Engineering circularly polarized luminescence through symmetry manipulation in achiral tetraphenylpyrazine structures. Chinese Journal of Structural Chemistry, 2025, 44(2): 100460-100460. doi: 10.1016/j.cjsc.2024.100460
4. [4]
  Sifan Du , Yuan Wang , Fulin Wang , Tianyu Wang , Li Zhang , Minghua Liu . Evolution of hollow nanosphere to microtube in the self-assembly of chiral dansyl derivatives and inversed circularly polarized luminescence. Chinese Chemical Letters, 2024, 35(7): 109256-. doi: 10.1016/j.cclet.2023.109256
5. [5]
  Yuwen Zhu , Xiang Deng , Yan Wu , Baode Shen , Lingyu Hang , Yuye Xue , Hailong Yuan . Formation mechanism of herpetrione self-assembled nanoparticles based on pH-driven method. Chinese Chemical Letters, 2025, 36(1): 109733-. doi: 10.1016/j.cclet.2024.109733
6. [6]
  Fang-Yuan Chen , Wen-Chao Geng , Kang Cai , Dong-Sheng Guo . Molecular recognition of cyclophanes in water. Chinese Chemical Letters, 2024, 35(5): 109161-. doi: 10.1016/j.cclet.2023.109161
7. [7]
  Jingqi Xin , Shupeng Han , Meichen Zheng , Chenfeng Xu , Zhongxi Huang , Bin Wang , Changmin Yu , Feifei An , Yu Ren . A nitroreductase-responsive nanoprobe with homogeneous composition and high loading for preoperative non-invasive tumor imaging and intraoperative guidance. Chinese Chemical Letters, 2024, 35(7): 109165-. doi: 10.1016/j.cclet.2023.109165
8. [8]
  Keyang Li , Yanan Wang , Yatao Xu , Guohua Shi , Sixian Wei , Xue Zhang , Baomei Zhang , Qiang Jia , Huanhua Xu , Liangmin Yu , Jun Wu , Zhiyu He . Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation. Chinese Chemical Letters, 2024, 35(10): 109511-. doi: 10.1016/j.cclet.2024.109511
9. [9]
  Xian Yan , Huawei Xie , Gao Wu , Fang-Xing Xiao . Boosted solar water oxidation steered by atomically precise alloy nanocluster. Chinese Chemical Letters, 2025, 36(1): 110279-. doi: 10.1016/j.cclet.2024.110279
10. [10]
  Feng Cao , Chunxiang Xian , Tianqi Yang , Yue Zhang , Haifeng Chen , Xinping He , Xukun Qian , Shenghui Shen , Yang Xia , Wenkui Zhang , Xinhui Xia . Gelation-pyrolysis strategy for fabrication of advanced carbon/sulfur cathodes for lithium-sulfur batteries. Chinese Chemical Letters, 2025, 36(3): 110575-. doi: 10.1016/j.cclet.2024.110575
11. [11]
  Fengying Ye , Ming Hu , Jun Luo , Wei Yu , Zhirong Xu , Jinjin Fu , Yansong Zheng . Significantly boosting circularly polarized luminescence by synergy of helical and planar chirality. Chinese Chemical Letters, 2025, 36(5): 110724-. doi: 10.1016/j.cclet.2024.110724
12. [12]
  Zhenzhu Wang , Chenglong Liu , Yunpeng Ge , Wencan Li , Chenyang Zhang , Bing Yang , Shizhong Mao , Zeyuan Dong . Differentiated self-assembly through orthogonal noncovalent interactions towards the synthesis of two-dimensional woven supramolecular polymers. Chinese Chemical Letters, 2024, 35(5): 109127-. doi: 10.1016/j.cclet.2023.109127
13. [13]
  Cheng Wang , Ji Wang , Dong Liu , Zhi-Ling Zhang . Advances in virus-host interaction research based on microfluidic platforms. Chinese Chemical Letters, 2024, 35(12): 110302-. doi: 10.1016/j.cclet.2024.110302
14. [14]
  Cheng He , Renlan Huang , Lingling Wei , Qiuhui He , Jinbo Liu , Jiao Chen , Ge Gao , Cheng Yang , Wanhua Wu . Uncovering the mask of sensitizers to switch on the TTA-UC emission by supramolecular host-guest complexation. Chinese Chemical Letters, 2025, 36(4): 110103-. doi: 10.1016/j.cclet.2024.110103
15. [15]
  Cheng-Yan Wu , Yi-Nan Gao , Zi-Han Zhang , Rui Liu , Quan Tang , Zhong-Lin Lu . Enhancing self-assembly efficiency of macrocyclic compound into nanotubes by introducing double peptide linkages. Chinese Chemical Letters, 2024, 35(11): 109649-. doi: 10.1016/j.cclet.2024.109649
16. [16]
  Changlin Su , Wensheng Cai , Xueguang Shao . Water as a probe for the temperature-induced self-assembly transition of an amphiphilic copolymer. Chinese Chemical Letters, 2025, 36(4): 110095-. doi: 10.1016/j.cclet.2024.110095
17. [17]
  Xingwen Cheng , Haoran Ren , Jiangshan Luo . Boosting the self-trapped exciton emission in vacancy-ordered double perovskites via supramolecular assembly. Chinese Journal of Structural Chemistry, 2024, 43(6): 100306-100306. doi: 10.1016/j.cjsc.2024.100306
18. [18]
  Xiaofei NIU , Ke WANG , Fengyan SONG , Shuyan YU . Self-assembly of [Pd₆(L)₄]⁸⁺-type macrocyclic complexes for fluorescent sensing of HSO₃^-. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1233-1242. doi: 10.11862/CJIC.20240057
19. [19]
  Zengchao Guo , Weiwei Liu , Tengfei Liu , Jinpeng Wang , Hui Jiang , Xiaohui Liu , Yossi Weizmann , Xuemei Wang . Engineered exosome hybrid copper nanoscale antibiotics facilitate simultaneous self-assembly imaging and elimination of intracellular multidrug-resistant superbugs. Chinese Chemical Letters, 2024, 35(7): 109060-. doi: 10.1016/j.cclet.2023.109060
20. [20]
  Tong Tong , Lezong Chen , Siying Wu , Zhong Cao , Yuanbin Song , Jun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(765)
HTML views(2)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142